The reported gross margin deterioration from positive territory to -21.0% in 2026Q2 suggests that the shift toward nanophotonic hardware has introduced significant COGS, likely from low-yield fabrication or third-party component costs. Operating margin of -4.1% in 2026Q2, though improved from -112.2% in 2025Q4, still reflects a cost structure where R&D and SG&A outpace the $5.6M quarterly revenue base. This implies that the company's earning power is entirely dependent on future productization, and current margins provide no evidence of a scalable path to profitability.

The ROIC trend from -14.6% to -1.2% appears to show improvement, but this is largely a denominator effect: total assets surged to $1.6B by 2026Q2, diluting the negative returns. The underlying operating losses of $23M in 2026Q2 against a $1.6B capital base imply that the company is not compounding returns but rather spreading losses over a larger equity cushion. This suggests that capital allocation has prioritized fundraising over operational efficiency, and investors should monitor whether the hardware pivot can generate positive incremental returns on the substantial invested capital.

The CCC transition from deeply negative to positive 266 days indicates that QUBT is now funding its operations through its own working capital rather than supplier credit, a reversal from earlier periods where DPO exceeded 8,000 days. DSO of 197 days in 2026Q2 suggests that revenue recognition is tied to slow-paying government contracts or pilot programs, while DIO of 115 days reflects inventory build-up for hardware production. This implies that the company's cash conversion is deteriorating as it scales, and the efficiency gains from supplier leverage are no longer available, warranting close monitoring of receivables collectability.

The absence of meaningful debt suggests that QUBT has not faced covenant or refinancing pressure, but this is a double-edged sword: the company has funded its $23M quarterly operating losses through equity raises, which have diluted shareholders. Interest coverage of -978.42 in 2026Q2 reflects negligible interest expense relative to operating losses, but the real risk is not debt service but the sustainability of equity issuance. If the reported cash of $189.2M in 2026Q2 is accurate, the runway appears adequate, but the reliance on equity markets for future funding could become a constraint if investor sentiment shifts.

The liquidity position appears exceptionally strong, with a current ratio of 53.13 and quick ratio of 52.44, indicating that current assets vastly exceed current liabilities. However, this liquidity is a function of the massive equity raises rather than operational cash generation, and the cash balance has already declined from $737.9M in 2025Q4 to $189.2M in 2026Q2, a 74% drawdown in two quarters. This suggests that while the company can weather near-term stress, the burn rate is accelerating, and the liquidity buffer could erode quickly if revenue growth does not materially improve.